Verition Fund Management LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 110 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,247,624
-58.4%
935,273
-47.7%
0.07%
-63.5%
Q2 2023$15,005,297
-3.4%
1,788,474
+14.3%
0.20%
-7.0%
Q1 2023$15,540,728
+43.3%
1,565,028
+0.4%
0.22%
+27.2%
Q4 2022$10,845,921
-15.5%
1,558,322
-67.6%
0.17%
+16.6%
Q3 2022$12,840,828
+69.3%
4,804,478
+152.7%
0.14%
-3.3%
Q2 2022$7,586,000
-19.0%
1,901,191
-9.7%
0.15%
+33.9%
Q1 2022$9,361,000
+71.2%
2,105,907
+54.1%
0.11%
+187.2%
Q4 2021$5,467,000
-34.3%
1,366,701
+44.1%
0.04%
-45.8%
Q3 2021$8,325,000
+39.2%
948,207
+79.6%
0.07%
+33.3%
Q2 2021$5,980,000
+20.8%
527,831
+26.7%
0.05%
-3.6%
Q1 2021$4,951,000
+266.7%
416,717
+111.8%
0.06%
+366.7%
Q4 2020$1,350,000
-38.5%
196,754
-33.6%
0.01%
-72.7%
Q3 2020$2,195,000
+2285.9%
296,180
+1246.3%
0.04%
+1366.7%
Q2 2020$92,000
-96.3%
22,000
-92.0%
0.00%
-96.9%
Q1 2019$2,485,000
+98.5%
275,205
+82.5%
0.10%
+7.8%
Q4 2018$1,252,000150,8050.09%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders